April - 2020

Companies in the News

eFFECTOR’s Zotatifin Demonstrates in vitro Anti-SARS-CoV-2 Activity in Independent International Stu

SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., today announced that preliminary results from an independent...

eFFECTOR’s Zotatifin (eFT226) Inhibited Tumor Growth and Caused Tumor Regression Across Diverse Rece

Study Presented in Virtual Session at AACR Annual Meeting Provides Evidence of Potential for Zotatifin to Drug an Important Class of...

GlaxoSmithKline injects US$250mln into US biotech Vir in coronavirus treatment collaboration

Vir's has two candidates that have proved highly potent in neutralising SARS-CoV-2 in live virus-cellular assays GlaxoSmithKline PLC...